Instituto Hermes Pardini SA
BOVESPA:PARD3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/IC
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Valuation Scenarios
If EV/IC returns to its 3-Year Average (1.4), the stock would be worth R$20.25 (0% downside from current price).
| Scenario | EV/IC Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.4 | R$20.25 |
0%
|
| 3-Year Average | 1.4 | R$20.25 |
0%
|
| 5-Year Average | 1.4 | R$20.25 |
0%
|
| Industry Average | 0.7 | R$9.9 |
-51%
|
| Country Average | 0.8 | R$11.28 |
-44%
|
Forward EV/IC
Today’s price vs future invested capital
Peer Comparison
| Market Cap | EV/IC | P/E | ||||
|---|---|---|---|---|---|---|
| BR |
|
Instituto Hermes Pardini SA
BOVESPA:PARD3
|
2.6B BRL | 1.4 | 15 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
105.9B USD | 0.8 | 59.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
72.9B EUR | 0.8 | 14.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
76.6B USD | 0 | 12.9 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.2B EUR | 0.8 | 18.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.4B EUR | 1 | 22.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.1B USD | 1.5 | 24.1 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.6B USD | 1.8 | 21.1 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 0.6 | 11 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.4B USD | 15.7 | -27.3 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD | 1.2 | 14.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.6 |
| Median | 0.8 |
| 70th Percentile | 1 |
| Max | 36.6 |
Other Multiples
Instituto Hermes Pardini SA
Glance View
Instituto Hermes Pardini SA engages in the provision of medical diagnostic services. The company is headquartered in Belo Horizonte, Minas Gerais and currently employs 7,500 full-time employees. The company went IPO on 2017-02-14. The firm provides various diagnostic and analytical services, including toxicological examination, clinical blood analysis, veterinary test, cryopreservation, diagnostic imaging, vaccination, deoxyribonucleic acid (DNA) screening test, as well as cardiometabolic examination, among others. The firm operates a number of healthcare units in the states of Minas Gerais and Sao Paulo, Brazil. The firm belongs to the Hermes Pardini Group.
